Sung Hwan LEE
GENOMIC BIOMARKERS TO PREDICT RESPONSE TO COMBINATION IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA
10:50-10:57 / BR OP 1
GENOMIC BIOMARKERS TO PREDICT RESPONSE TO COMBINATION IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA
10:50-10:57 / BR OP 1
Yeshong PARK
GENOMIC ANALYSIS OF COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA REVEALS COMMON LINEAGE OF TUMOR COMPONENTS WITH UNIQUE GENE EXPRESSION PROFILE
10:57-11:04 / BR OP 2
GENOMIC ANALYSIS OF COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA REVEALS COMMON LINEAGE OF TUMOR COMPONENTS WITH UNIQUE GENE EXPRESSION PROFILE
10:57-11:04 / BR OP 2
Ssang-Goo CHO
11:04-11:11 / BR OP 3
11:04-11:11 / BR OP 3
Mun Chae CHOI
DEVELOPMENT AND OPTIMIZATION OF TRANSPLANT SURGEON-INNOVATED EVMP: VALIDATION IN A PORCINE DCD LIVER TRANSPLANT MODEL
11:11-11:18 / BR OP 4
DEVELOPMENT AND OPTIMIZATION OF TRANSPLANT SURGEON-INNOVATED EVMP: VALIDATION IN A PORCINE DCD LIVER TRANSPLANT MODEL
11:11-11:18 / BR OP 4
Chae Eun LEE
DEVELOPMENT OF IMMUNE-EVASIVE META-SOFT ORGAN MODULES THROUGH ADVANCED CELL ENGINEERING AND ASSEMBLY TECHNOLOGY
11:18-11:25 / BR OP 5
DEVELOPMENT OF IMMUNE-EVASIVE META-SOFT ORGAN MODULES THROUGH ADVANCED CELL ENGINEERING AND ASSEMBLY TECHNOLOGY
11:18-11:25 / BR OP 5
Min Kyu SUNG
DEVELOPMENT OF A COLLAGEN-PERIOSTIN BASED DRUG EVALUATION PLATFORM USING PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS
11:25-11:32 / BR OP 6
DEVELOPMENT OF A COLLAGEN-PERIOSTIN BASED DRUG EVALUATION PLATFORM USING PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS
11:25-11:32 / BR OP 6
A-Reum KIM
THERAPEUTIC POTENTIAL OF EXOSOMES FROM HUMAN CHEMICALLY DERIVED HEPATIC PROGENITOR CELLS (HCDHS) IN LIVER DAMAGE
11:32-11:39 / BR OP 7
THERAPEUTIC POTENTIAL OF EXOSOMES FROM HUMAN CHEMICALLY DERIVED HEPATIC PROGENITOR CELLS (HCDHS) IN LIVER DAMAGE
11:32-11:39 / BR OP 7
Sun Jae PARK
DEVELOPMENT AND VALIDATION OF A NOVEL DIGITAL PCR ASSAY TARGETING CIRCULATING TUMOR DNA METHYLATION BIOMARKERS FOR HEPATOCELLULAR CARCINOMA SCREENING.
11:39-11:48 / BR OP 8
DEVELOPMENT AND VALIDATION OF A NOVEL DIGITAL PCR ASSAY TARGETING CIRCULATING TUMOR DNA METHYLATION BIOMARKERS FOR HEPATOCELLULAR CARCINOMA SCREENING.
11:39-11:48 / BR OP 8